Numeric Investors’s Adverum Biotechnologies ADVM Stock Holding History

Numeric Investors’s Portfolio ADVM Stock Details ADVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$874K	Sell	24,970 -1,970	-7%	-$64.8K	0.01%	771
2017 Q3	$983K	Sell	26,940 -28,975	-52%	-$804K	0.01%	759
2017 Q2	$1.4M	Sell	55,915 -52,882	-49%	-$1.45M	0.01%	596
2017 Q1	$2.94M	Sell	108,797 -14,738	-12%	-$419K	0.03%	412
2016 Q4	$3.58M	Buy	123,535 +980	+0.8%	+$32K	0.03%	388
2016 Q3	$5.04M	Buy	122,555 +9,062	+8%	+$344K	0.05%	314
2016 Q2	$3.59M	Buy	113,493 +15,062	+15%	+$681K	0.03%	346
2016 Q1	$5.09M	Sell	98,431 -21,093	-18%	-$1.18M	0.05%	282
2015 Q4	$11.4M	Buy	119,524 +45,171	+61%	+$3.97M	0.12%	179
2015 Q3	$6.13M	Buy	74,353 +48,643	+189%	+$6.21M	0.07%	224
2015 Q2	$4.17M	Buy	+25,710	New	+$8.67M	0.05%	280

Other funds holding ADVM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Numeric Investors's ADVM Position: Q4 2017 in Review

Numeric Investors reduced its Adverum Biotechnologies (ADVM) stake by 7.3% in Q4 2017, selling an estimated $64.8K and leaving 24,970 shares worth $874K. The position accounts for 0.01% of the portfolio, ranked #771.

Numeric Investors first reported a position in ADVM in Q2 2015 and has held it in 11 quarters since. The position peaked at $11.4M in Q4 2015. 65 funds tracked by Wall St. Rank hold ADVM as of Q4 2017.

Numeric Investors held 24,970 shares of Adverum Biotechnologies worth $874K as of Q4 2017.
Numeric Investors sold 1,970 Adverum Biotechnologies shares in Q4 2017, an estimated $64.8K.
Adverum Biotechnologies made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #771 holding.
Numeric Investors first reported a position in Adverum Biotechnologies in Q2 2015 and has held it in 11 quarters since.
Numeric Investors's Adverum Biotechnologies position peaked at $11.4M in Q4 2015.
65 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.